Anchor sleeve for implantable lead

ABSTRACT

An anchor sleeve for securing a therapy delivery element, such as a stimulation lead or catheter, within a living body, that includes an inner sleeve with pre-formed locations of weakness that facilitate localized deformation. The anchor includes a deformable outer sleeve with a primary lumen extending along an axis. The outer surface of the outer sleeve includes a plurality of suture grooves oriented generally concentric to the axis. The inner sleeve includes a plurality of beams connected at deflection regions arranged around a secondary lumen. The inner sleeve is located in the primary lumen adjacent to the suture grooves so that the secondary lumen is generally concentric with the primary lumen. A plurality of locations of weakness are preformed in each of the beams to facilitate localized deformation in response to a radially inward force applied around the suture grooves by a suture material.

CLAIM OF PRIORITY

This application is a continuation of and claims the benefit of priorityunder 35 U.S.C. §120 to Daglow, U.S. patent application Ser. No.13/045,947,now U.S. Pat. No. 8,849,418, entitled “ANCHOR SLEEVE FORIMPLANTABLE LEAD”, filed on Mar. 11, 2011, which is incorporated byreference herein in its entirety.

FIELD

The present disclosure relates to an anchor sleeve for securing atherapy delivery element, such as a stimulation lead or catheter, withina living body. The anchor includes an inner sleeve with pre-formedlocations of weakness that facilitate localized deformation around thetherapy delivery element.

BACKGROUND

Implantable medical devices are used for a wide variety of medicalconditions, such as for example, cardiac pace making, cardiac rhythmmanagement, treatments for congestive heart failure, implanteddefibrillators, and neurostimulation. Neurostimulation encompasses awide range of applications, such as for example, pain control, nervoustremor mitigation, incontinent treatment, epilepsy seizure reduction,and vagus nerve stimulation for clinical depression.

These implantable medical devices generally include an implanted pulsegenerator that generates electrical pulses or signals that aretransmitted to a targeted tissue or nerves through a therapy deliveryelement, such as a lead with electrodes. Controlled placement of thetherapy delivery element is required for improved therapeutic efficacyor reduced side effects. Retaining the implanted therapy deliveryelement in the desired location also creates difficulties because thelocation may change over time as the patient moves. A variety of anchorsare available to prevent the therapy delivery element from migratingaway from a specifically selected stimulation site.

U.S. Pat. No. 4,553,961 (Pohndorf et al.) discloses a typical suturesleeve with an outer elastomeric sleeve and an inner gripping structure.The lead is inserted though a lumen in the anchor. The grippingstructure is radially compressed by tying of sutures around the suturesleeve.

Clinicians inserting and anchoring therapy delivery elements typicallyprefer to perform the procedure rapidly, in a minimally invasive manner,and fix the therapy delivery element in a manner that reduces theopportunity for the therapy delivery element to migrate if practicable.Examples of some previous anchors are shown in U.S. Pat. No. 6,134,477“Adjustable Medical Lead Fixation System” by Knuteson (Oct. 17, 2000);U.S. Pat. No. 5,484,445 “Sacral Lead Anchoring System” by Knuth (Jan.16, 1996); and, U.S. Pat. No. 5,843,146. “Adjustable Medical LeadAnchor” by Cross, Jr. (Dec. 1, 1998).

BRIEF SUMMARY

The present disclosure relates to an anchor sleeve for securing atherapy delivery element, such as a stimulation lead or catheter, withina living body. The anchor includes an inner sleeve with pre-formedlocations of weakness that facilitate localized deformation around thetherapy delivery element.

In one embodiment, the anchor includes a deformable outer sleeve with aprimary lumen extending along an axis. The outer surface of the outersleeve includes a plurality of suture grooves oriented generallyconcentric to the axis. The inner sleeve includes a plurality of beamsconnected at deflection regions arranged around a secondary lumen. Theinner sleeve is located in the primary lumen adjacent to the suturegrooves so that the secondary lumen is generally concentric with theprimary lumen. A plurality of locations of weakness are preformed ineach of the beams to facilitate localized deformation in response to aradially inward force applied around the suture grooves by a suturematerial.

The outer sleeve typically includes distal portions extending beyond theinner sleeve. In one embodiment, at least a portion of the primary lumenincludes grooves adapted to receive a medical adhesive. The outer sleeveoptionally includes one or more fill ports adapted to direct a medicaladhesive to at least the primary lumen. The at least one fill portpreferably includes a connector to receive a dispenser containing amedical adhesive. The outer sleeve is preferably constructed from anelastomeric material.

The inner sleeve is made from a material that plastically or elasticallydeforms in response to the radially inward force, such as for example, athermoplastic material, stainless steel, or Nitinol. The locations ofweakness are typically discontinuities in the beams, such as slits,holes, recesses, regions thinning, or a combination thereof. Thelocalized deformation can be one or more of bending, twisting,elongation, compression, or a combination thereof.

The present disclosure is also directed to a neurostimulation systemincluding an implantable pulse generator and a therapy delivery element.The therapy delivery element includes a proximal end adapted toelectrically couple with the implantable pulse generator, and a distalend with a plurality of electrodes electrically coupled to theimplantable pulse generator. The present anchor is provided to securethe therapy delivery element in a desired location within a living body.

The present disclosure is also directed to a method of securing atherapy delivery element at a desired location within a living body. Themethod includes the steps of inserting the therapy delivery elementthrough lumens of an anchor. The anchor includes an outer sleeve with aprimary lumen and an inner sleeve with a secondary lumen located withinthe primary lumen. The primary lumen is generally concentric with thesecondary lumen. The anchor is slid along the therapy delivery elementto the desired location. A suture material is wrapped around at leastone suture groove aligned with the inner sleeve that is foiined in anouter surface of the outer sleeve. A radially inward force is applied atthe suture groove by tensioning the suture material. The radially inwardforce creates localized deformation at locations of weakness preformedin beams of the inner sleeve. The inner sleeve compressively engages thetherapy delivery element. The suture material is used to attach theanchor to the desired location within the living body.

The present method optionally includes the steps of coupling a dispensercontaining a medical adhesive to a fill port on the outer sleeve anddelivering the medical adhesive to at least the primary lumen. Themedical adhesive is preferably delivered to at least the primary lumenbefore the step of applying the radially inward force at the suturegroove.

The present disclosure is also directed to a method of implanting aneurostimulation system within a living body. The method includes thesteps of implanting an implantable pulse generator within the livingbody. Electrodes at a distal end of a therapy delivery element arepositioned at a target location within the living body. A proximal endof the therapy delivery element is inserted into lumens in the presentanchor. The anchor is slide along the therapy delivery element to adesired location. A suture material is wrapped around at least onesuture groove aligned with the inner sleeve that is formed in an outersurface of the outer sleeve. A radially inward force is applied at thesuture groove by tensioning the suture material. The radially inwardforce creates localized deformation at locations of weakness preformedin beams of the inner sleeve. The inner sleeve compressively engages thetherapy delivery element. The suture material attaches the anchor totissue within the living body. The proximal end of the therapy deliveryelement is electrically coupled to the implantable pulse generator.

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING

FIG. 1A is a schematic illustration of a therapy delivery system.

FIG. 1B is a schematic illustration of an environment for a therapydelivery system in accordance with an embodiment of the presentdisclosure.

FIG. 1C is an alternate illustration of the environment for animplantable pulse generator with a therapy delivery element inaccordance with an embodiment of the present disclosure.

FIG. 2 is a sectional view of an anchor for a therapy delivery elementin accordance with an embodiment of the present disclosure.

FIG. 3 is a perspective view an inner sleeve for the anchor of FIG. 2.

FIG. 4A is a vertical cross-sectional view of the inner sleeve of FIG.3.

FIG. 4B is a horizontal cross-sectional view of the inner sleeve of FIG.3.

FIG. 5 illustrates an adhesive reservoir coupled to the anchor of FIG. 2in accordance with an embodiment of the present disclosure.

FIG. 6 is an enlarged view of a fill tube coupled to the anchor of FIG.2.

FIG. 7 is a sectional view of a therapy delivery element positioned inthe anchor of FIG. 2.

FIG. 8 is a sectional view of the anchor of FIG. 2 compressed onto atherapy delivery element with sutures in accordance with an embodimentof the present disclosure.

FIG. 9 is a flow chart of a method of using the present anchor inaccordance with an embodiment of the present disclosure.

FIG. 10 is a flow chart of an alternate method of using the presentanchor in accordance with an embodiment of the present disclosure.

FIG. 11 is a flow chart of a method of implanting a therapy deliverysystem using the present anchor in accordance with an embodiment of thepresent disclosure.

FIG. 12 is a perspective view of an alternate inner sleeve in accordancewith an embodiment of the present disclosure.

DETAILED DESCRIPTION OF SOME EMBODIMENTS

The description that follows relates to a spinal cord stimulation (SCS)system. However, it is to be understood that the while the presentdisclosure lends itself well to applications in SCS, the disclosure inits broadest aspects may not be so limited. Rather, the disclosure maybe used with any type of implantable therapy delivery system with one ormore therapy delivery elements. For example, the present disclosure maybe used as part of a pacemaker, a defibrillator, a cochlear stimulator,a retinal stimulator, a stimulator configured to produce coordinatedlimb movement, a cortical stimulator, a deep brain stimulator,peripheral nerve stimulator, microstimulator, or in any other neuralstimulator configured to treat urinary incontinence, sleep apnea,shoulder sublaxation, headache, etc.

In another embodiment, one or more of the therapy delivery elements maybe a fluid delivery conduit, such as a catheter, including an innerlumen that is placed to deliver a fluid, such as pharmaceutical agents,insulin, pain relieving agents, gene therapy agents, or the like from afluid delivery device (e.g., a fluid reservoir and/or pump) to arespective target tissue site in a patient.

In yet another embodiment, one or more of the therapy delivery elementsmay be an electrical lead including one or more sensing electrodes tosense physiological parameters (e.g., blood pressure, temperature,cardiac activity, etc.) at a target tissue site within a patient. In thevarious embodiments contemplated by this disclosure, therapy may includestimulation therapy, sensing or monitoring of one or more physiologicalparameters, fluid delivery, and the like. “Therapy delivery element”includes pacing or defibrillation leads, stimulation leads, sensingleads, fluid delivery conduit, extensions for any of the above, orcombinations thereof. “Target tissue site” refers generally to thetarget site for implantation of a therapy delivery element, regardlessof the type of therapy.

FIG. 1A illustrates a generalized therapy delivery system 10 that may beused in spinal cord stimulation (SCS), as well as other stimulationapplications. The therapy delivery system 10 generally includes animplantable pulse generator 12, an implantable therapy delivery element14, which carries an array of electrodes 18 (shown exaggerated forpurposes of illustration), and an optional implantable extension lead16. Although only one therapy delivery element 14 is shown, typicallytwo or more therapy delivery elements 14 are used with the therapydelivery system 10 (See e.g., FIG. 1C).

The therapy delivery element 14 includes elongated body 40 having aproximal end 36 and a distal end 44. The elongated body 40 typically hasa diameter of between about 0.03 inches to 0.07 inches and a lengthwithin the range of 30 cm to 90 cm for spinal cord stimulationapplications. The elongated body 40 may be composed of a suitableelectrically insulative material, such as, a polymer (e.g., polyurethaneor silicone), and may be extruded from as a unibody construction.

In the illustrated embodiment, proximal end 36 of the therapy deliveryelement 14 is electrically coupled to distal end 38 of the extensionlead 16 via a connector 20, typically associated with the extension lead16. Proximal end 42 of the extension lead 16 is electrically coupled tothe implantable pulse generator 12 via connector assembly 22 associatedwith housing 28. Alternatively, the proximal end 36 of the therapydelivery element 14 can be electrically coupled directly to theconnector 20.

In the illustrated embodiment, the implantable pulse generator 12includes electronic subassembly 24 (shown schematically), which includescontrol and pulse generation circuitry (not shown) for deliveringelectrical stimulation energy to the electrodes 18 of the therapydelivery element 14 in a controlled manner, and a power supply, such asbattery 26.

The implantable pulse generator 12 provides a programmable stimulationsignal (e.g., in the form of electrical pulses or substantiallycontinuous-time signals) that is delivered to target stimulation sitesby electrodes 18. In applications with more than one therapy deliveryelement 14, the implantable pulse generator 12 may provide the same or adifferent signal to the electrodes 18.

Alternatively, the implantable pulse generator 12 can take the form ofan implantable receiver-stimulator in which the power source forpowering the implanted receiver, as well as control circuitry to commandthe receiver-stimulator, are contained in an external controllerinductively coupled to the receiver-stimulator via an electromagneticlink. In another embodiment, the implantable pulse generator 12 can takethe form of an external trial stimulator (ETS), which has similar pulsegeneration circuitry as an IPG, but differs in that it is anon-implantable device that is used on a trial basis after the therapydelivery element 14 has been implanted and prior to implantation of theIPG, to test the responsiveness of the stimulation that is to beprovided.

The housing 28 is composed of a biocompatible material, such as forexample titanium, and forms a hermetically sealed compartment containingthe electronic subassembly 24 and battery 26 is protected from the bodytissue and fluids. The connector assembly 22 is disposed in a portion ofthe housing 28 that is, at least initially, not sealed. The connectorassembly 22 carries a plurality of contacts that electrically couplewith respective terminals at proximal ends of the therapy deliveryelement 14 or extension lead 16. Electrical conductors extend from theconnector assembly 22 and connect to the electronic subassembly 24.

FIG. 1B illustrates the therapy delivery element 14 implanted in theepidural space 30 of a patient in close proximity to the dura, the outerlayer that surrounds the spinal cord 32, to deliver the intendedtherapeutic effects of spinal cord electrical stimulation. The targetstimulation sites may be anywhere along the spinal cord 32, such as forexample proximate the sacral nerves.

Because of the lack of space near the lead exit point 34 where thetherapy delivery element 14 exits the spinal column, the implantablepulse generator 12 is generally implanted in a surgically-made pocketeither in the abdomen or above the buttocks, such as illustrated in FIG.1C. The implantable pulse generator 12 may, of course, also be implantedin other locations of the patient's body. Use of the extension lead 16facilitates locating the implantable pulse generator 12 away from thelead exit point 34. In some embodiments, the extension lead 16 serves asa lead adapter if the proximal end 36 of the therapy delivery element 14is not compatible with the connector assembly 22 of the implantablepulse generator 12, since different manufacturers use differentconnectors at the ends of their stimulation leads and are not alwayscompatible with the connector assembly 22.

As illustrated in FIG. 1C, the therapy delivery system 10 also mayinclude a clinician programmer 46 and a patient programmer 48. Clinicianprogrammer 46 may be a handheld computing device that permits aclinician to program neurostimulation therapy for patient using inputkeys and a display. For example, using clinician programmer 46, theclinician may specify neurostimulation parameters for use in delivery ofneurostimulation therapy. Clinician programmer 46 supports telemetry(e.g., radio frequency telemetry) with the implantable pulse generator12 to download neurostimulation parameters and, optionally, uploadoperational or physiological data stored by implantable pulse generator12. In this manner, the clinician may periodically interrogate theimplantable pulse generator 12 to evaluate efficacy and, if necessary,modify the stimulation parameters.

Similar to clinician programmer 46, patient programmer 48 may be ahandheld computing device. Patient programmer 48 may also include adisplay and input keys to allow patient to interact with patientprogrammer 48 and the implantable pulse generator 12. The patientprogrammer 48 provides patient with an interface for control ofneurostimulation therapy provided by the implantable pulse generator 12.For example, patient may use patient programmer 48 to start, stop oradjust neurostimulation therapy. In particular, patient programmer 48may permit patient to adjust stimulation parameters such as duration,amplitude, pulse width and pulse rate, within an adjustment rangespecified by the clinician via clinician programmer 48, or select from alibrary of stored stimulation therapy programs.

The implantable pulse generator 12, clinician programmer 46, and patientprogrammer 48 may communicate via cables or a wireless communication.Clinician programmer 46 and patient programmer 48 may, for example,communicate via wireless communication with the implantable pulsegenerator 12 using RF telemetry techniques known in the art. Clinicianprogrammer 46 and patient programmer 48 also may communicate with eachother using any of a variety of local wireless communication techniques,such as RF communication according to the 802.11 or Bluetoothspecification sets, infrared communication, e.g., according to the IrDAstandard, or other standard or proprietary telemetry protocols.

Since the implantable pulse generator 12 is located remotely from targetlocation 49 for therapy, the therapy delivery element 14 and/or theextension leads 16 is typically routed through a pathways subcutaneouslyformed along the torso of the patient to a subcutaneous pocket where theimplantable pulse generator 12 is located. As used hereinafter, “lead”and “lead extension” are used interchangeably, unless content clearlydictates otherwise.

The therapy delivery elements 14 are typically fixed in place near thelocation selected by the clinician using anchor 47, such as in theepidural space 30. The anchor 47 can be positioned on the therapydelivery element 14 in a wide variety of locations and orientations toaccommodate individual anatomical differences and the preferences of theclinician. The anchor 47 may then be affixed to tissue using fasteners,such as for example, one or more sutures, staples, screws, or otherfixation devices. The tissue to which the anchor 47 is affixed mayinclude subcutaneous fascia layer, bone, or some other type of tissue.Securing the anchor 47 to tissue in this manner prevents or reduces thechance that the therapy delivery element 14 will become dislodged orwill migrate in an undesired manner.

FIG. 2 is a sectional view of outer sleeve 50 revealing inner sleeve 52of anchor 47 in accordance with an embodiment of the present disclosure.Outer sleeve 50 includes primary lumen 54 extending along axis A fromfirst opening 56A to second opening 56B (“56”). The outer sleeve 50preferably has distal portions 58A, 58B that extend beyond the innersleeve 52.

In the illustrated embodiment, inner surface 60 of the primary lumen 54includes one or more spiral grooves 62, used to channel medicaladhesive, as will be discussed further below. Outer surface 64 includesone or more suture grooves 66 around which suture material 68 is wrapped(see FIG. 8) to compress the anchor 47 onto a therapy delivery element14. The suture grooves 66 are preferably axially aligned with the innersleeve 52 along axis A. The outer sleeve 50 optionally includes one ormore fill ports 70A, 70B, 70C, 70D (“70”) used to direct a medicaladhesive (see FIG. 7) to at least primary lumen 54. The outer sleeve 52is preferably injection molded using elastomeric material, such as forexample, medical grade silicone.

FIG. 3 is a perspective view of the inner sleeve 52 separated from theouter sleeve 50. The inner sleeve 52 includes a series of beams 72A,72B, 72C, 72D (“72”) connected by deflection region 74A, 74B, 74C, 74D(“74”). The beams 72 are configured in a serpentine pattern so that eachbeam 72 has multiple deflection regions 74. For example, beam 72A isattached to the inner sleeve 52 at deflection regions 74A, 74B. In theillustrated embodiment, deflection region 74A is oriented and actsgenerally perpendicular to deflection region 74B.

The number of beams 72 can vary depending on the application. In theillustrated embodiment the beams 72 are configured with secondary lumen76 also extending along axis A. The secondary lumen 76 of the innersleeve 52 and the primary lumen 54 of the outer sleeve 50 are preferablyboth positioned concentrically relative to the axis A.

The inner sleeve 52 can be made from a variety of plastically and/orelastically deformable materials, such as for example, nylon, stainlesssteel, Nitinol, and the like. In another embodiment, the inner sleeve 52is treated to be radiopaque. In one embodiment, the inner sleeve 52 isstainless steel formed by wire electro-discharge machining processes.

FIG. 4A is a top view of the inner sleeve 52 of FIG. 3. FIG. 4B is aside view of a vertical section of the inner sleeve 52 taken throughdeflection region 74A, 74D. In one embodiment, the beams 72 can deflectin pairs, such a for example, beams 72A, 72B may simultaneously deflectaround deflection regions 74A, 74D. The deflection can be one or more oflinear or rotary displacement, bending, twisting, or a combinationthereof. The deflection preferably encompasses at least three degrees offreedom.

Each beam 72 includes a plurality of locations of weakness 80 thatfacilitate localized deformation (see e.g., FIG. 8). The localizeddeformation is preferably plastic, but can also be elastic, or acombination of elastic and plastic deformation. In the illustratedembodiment, the locations of weakness 80 are a plurality of slits 82extending through the beams 72. As used herein, “location of weakness”refers to any discontinuity in a beam structure that facilitateslocalized deformation, such as for example, slits, holes, recesses,regions thinning, and the like. The deformation can be one or more oflinear or rotary displacement, deflection, bending, twisting.

FIGS. 5 and 6 illustrate an embodiment in which anchor 47 is infusedwith medical adhesive 102 after the anchor 47 is positioned in thedesired location along the therapy delivery element 14. The medicaladhesive 102 is located in dispenser 106. Dispenser 106 includes adaptor108 with a fill tube 110 and a coupling 112 configured to engage withfill port 70A on outer sleeve 50. In one embodiment, the coupling 112and the fill ports 70 include complimentary threats. Because the medicaladhesive 102 is applied after the anchor 47 is prepositioned on thetherapy delivery element 14, better bonding results. Moreover, there isno need to slide the anchor 47 into place after the adhesive 102 isapplied.

In the embodiment illustrated in FIG. 7, the anchor 47 is infused withthe medical adhesive 102 before the sutures 68 are applied. Theuncompressed lumens 54, 76 permits the medical adhesive 102 to flow intoand around inner sleeve 52.

Before the medical adhesive cures, sutures 68 are wrapped around suturegrooves 66 on the outer sleeve 50, as illustrated in FIG. 8. The sutures68 provide a radially compressive force 114 localized at the suturegrooves 66. The sutures 68 also attached the anchor 47 to adjacenttissue in the patient (see FIG. 1). The radially compressive force 114causes excess adhesive 102 may flow out openings 56A, 56B or the otherfill ports 70B, 70C, 70D.

The portion of the lumens 54, 76 and the inner sleeve 52 adjacent to thesutures 68 are compressed. Beams 72 of the inner sleeve 52 are deflectedinward, while locations of weakness 80 facilitate localized deformation116 of the beam 72. The localized deformation 116 increases grippingforce 118 between the inner sleeve 50 and the therapy delivery element14. Once the adhesive 102 cures, the inner sleeve 52 is fixed in thedeformed configuration 116 created by the radially compressive force114.

In an alternate embodiment, the anchor 47 may be used without themedical adhesive 102. In the preferred embodiment, the beams 72 areadapted to deform in at least three degrees of freedom—linear and/orrotary displacement; localized bending, and twisting.

In an alternate embodiment, the medical adhesive 102 may be infused intothe anchor 100 after the sutures 68 are applied. See also FIG. 10. Theradially compressive force 114 restricts the flow the adhesive 102within the primary lumen 54, resulting in the adhesive concentrating inthe distal end 58A of the outer sleeve 50. In this embodiment, it isdesirable to also deliver adhesive 102 through fill ports 70B or 70D soinfuse distal end 58B of the outer sleeve 50.

The medical adhesive 102 can be any type of biocompatible medical-gradeadhesive. Such medical adhesive includes polyurethane and/or siliconeadhesives. One example is Room Temperature Vulcanization (RTV) siliconeadhesive which cures at room temperature. This type of adhesive iscommercially available in tubes having a threaded neck similar to thatshown and described below in reference to FIG. 5. This type of adhesiveis generally kept under pressure to prevent it from curing at roomtemperature. When pressure is removed (e.g., the adhesive is dispensedfrom the tube) the adhesive will set up, becoming solid, or semi-solidin nature. Another example is a silicone or polyurethane adhesive thatcures when exposed to UV or visible light, as is available from theDymax Corporation.

FIG. 9 is a flow diagram of one method in accordance with an embodimentof the present disclosure. The therapy delivery element is firstpositioned in the patient (150). The proximal end of the therapydelivery element is slid through a lumen of an anchor (152). The anchoris then positioned in the desired location along the therapy deliveryelement in the patient (154). A dispenser is coupled to a fill port onthe anchor (156). A medical adhesive is delivered into the anchor (158).The fill tube on the dispenser is detached from the anchor (160). Asuture material is wrapped around suture grooves on the anchor (162).The suture material is tensioned to provide a radially compressive forceto the anchor to create localized deformation of an inner sleeve (164).The suture material is also attached to the patient (166).

FIG. 10 is a flow diagram of an alternate method in accordance with anembodiment of the present disclosure. The therapy delivery element isfirst positioned in the patient (170). The proximal end of the therapydelivery element is slid through a lumen of an anchor (172). The anchoris then positioned in the desired location along the therapy deliveryelement in the patient (174). A suture material is wrapped around suturegrooves on the anchor (176). The suture material is tensioned to providea radially compressive force to the anchor to create localizeddeformation of an inner sleeve (178). The suture material is alsoattached to the patient (180). A dispenser is coupled to a fill port onthe anchor (182). A medical adhesive is delivered into the anchor (184).The fill tube on the dispenser is detached from the anchor (186).

FIG. 11 is a flow diagram of a method of implanting a therapy deliverysystem in accordance with an embodiment of the present disclosure. Themethod includes the steps of implanting an implantable pulse generatorwithin the living body (200). Electrodes at a distal end of a therapydelivery element are positioned at a target location within the livingbody (202). A proximal end of the therapy delivery element is insertedinto lumens in the present anchor (204). The anchor is slid along thetherapy delivery element to a desired location (206). A suture materialis wrapped around at least one suture groove aligned with the innersleeve that is formed in an outer surface of the outer sleeve (208). Aradially inward force is applied at the suture groove by tensioning thesuture material (210). The radially inward force creates localizeddeformation at locations of weakness preformed in beams of the innersleeve. The inner sleeve compressively engages the therapy deliveryelement (212). The suture material attaches the anchor to tissue withinthe living body (214). The proximal end of the therapy delivery elementis electrically coupled to the implantable pulse generator (216).

FIG. 12 is a perspective view of an alternate inner sleeve 220 inaccordance with an embodiment of the present disclosure. Center ring 222includes a plurality of cantilevered beams 224 arranged parallel to thecenter axis A and concentric with secondary lumen 226. Holes 228 areprovided to facility the flow of adhesive and/or deformation of thecenter ring 222. Attachment points 232 facilitate rotation displacementand twisting of the beams 224 relative to the center ring 222.

Each of the beams 224 preferably includes a plurality of locations ofweakness 230 that facilitate localized deformation. The localizeddefolination can be one or more of bending, twisting, elongation,compression, or a combination thereof.

Where a range of values is provided, it is understood that eachintervening value, to the tenth of the unit of the lower limit unlessthe context clearly dictates otherwise, between the upper and lowerlimit of that range and any other stated or intervening value in thatstated range is encompassed within this disclosure. The upper and lowerlimits of these smaller ranges which may independently be included inthe smaller ranges is also encompassed within the disclosure, subject toany specifically excluded limit in the stated range. Where the statedrange includes one or both of the limits, ranges excluding either bothof those included limits are also included in the disclosure.

Unless defined otherwise, all technical and scientific terms used hereinhave the same meaning as commonly understood by one of ordinary skill inthe art to which this disclosure belongs. Although any methods andmaterials similar or equivalent to those described herein can also beused in the practice or testing of the various methods and materials arenow described. All patents and publications mentioned herein, includingthose cited in the Background of the application, are herebyincorporated by reference to disclose and described the methods and/ormaterials in connection with which the publications are cited.

The publications discussed herein are provided solely for theirdisclosure prior to the filing date of the present application. Nothingherein is to be construed as an admission that the present disclosure isnot entitled to antedate such publication by virtue of prior invention.Further, the dates of publication provided may be different from theactual publication dates which may need to be independently confirmed.

Other embodiments are possible. Although the description above containsmuch specificity, these should not be construed as limiting the scope ofthe disclosure, but as merely providing illustrations of some of thepresently preferred embodiments. It is also contemplated that variouscombinations or sub-combinations of the specific features and aspects ofthe embodiments may be made and still fall within the scope of thisdisclosure. It should be understood that various features and aspects ofthe disclosed embodiments can be combined with or substituted for oneanother in order to form varying modes disclosed. Thus, it is intendedthat the scope of at least some of the present disclosure should not belimited by the particular disclosed embodiments described above.

Thus the scope of this disclosure should be determined by the appendedclaims and their legal equivalents. Therefore, it will be appreciatedthat the scope of the present disclosure fully encompasses otherembodiments which may become obvious to those skilled in the art, andthat the scope of the present disclosure is accordingly to be limited bynothing other than the appended claims, in which reference to an elementin the singular is not intended to mean “one and only one” unlessexplicitly so stated, but rather “one or more.” All structural,chemical, and functional equivalents to the elements of theabove-described preferred embodiment that are known to those of ordinaryskill in the art are expressly incorporated herein by reference and areintended to be encompassed by the present claims. Moreover, it is notnecessary for a device or method to address each and every problemsought to be solved by the present disclosure, for it to be encompassedby the present claims. Furthermore, no element, component, or methodstep in the present disclosure is intended to be dedicated to the publicregardless of whether the element, component, or method step isexplicitly recited in the claims.

What is claimed is:
 1. An anchor for securing a therapy delivery elementto a desired location within a living body, the anchor comprising: adeformable outer sleeve including a primary lumen extending along anaxis; an inner sleeve including a plurality of beams connected atdeflection regions arranged around a secondary lumen, the inner sleevelocated in and substantially concentric with the primary lumen, whereinthe inner sleeve is fixed within the primary lumen of the outer sleeve;and a plurality of locations of weakness in each of the beams thatfacilitate localized deformation of the inner sleeve in response to aradially inward force, the plurality of locations of weakness includinga plurality of slits extending part-way through a beam width from both afirst beam edge and a second beam edge, wherein the slits alternate fromextending into the beam width from the first edge to extending from thesecond edge without being in open communication with each other as theslits extend along the length of the beam, wherein the inner sleevebuckles at the slits in response to the radially inward force to gripthe therapy delivery element disposed within the inner sleeve.
 2. Theanchor of claim 1, wherein the outer sleeve includes an outer surfaceincluding at least one suture-receiving portion.
 3. The anchor of claim2, wherein the at least one suture-receiving portion includes at leastone suture groove oriented substantially concentrically to the axis. 4.The anchor of claim 2, wherein the radially inward force is appliedaround the suture-receiving portion by a suture material.
 5. The anchorof claim 1, wherein the outer sleeve includes at least a portionextending beyond the inner sleeve.
 6. The anchor of claim 1, wherein atleast a portion of the primary lumen includes a medical adhesivereceiving groove.
 7. The anchor of claim 1, wherein the outer sleeveincludes a fill port adapted to direct a medical adhesive to at leastthe primary lumen.
 8. An anchor for securing a therapy delivery elementto a desired location within a living body, the anchor comprising: adeformable outer sleeve including a primary lumen extending along anaxis; and an inner sleeve disposed within the outer sleeve, the innersleeve being fixed within the primary lumen of the outer sleeve, theinner sleeve including at least two beams and a location of weaknesswithin at least one of the beams configured to facilitate localizeddeformation of the inner sleeve in response to a radially inward force,the location of weakness including at least a first slit and a secondslit each extending part-way through a beam width, wherein the firstslit extends into the beam width from a first edge and the second slitextends into the beam width from a second edge without being in opencommunication with each other, wherein the inner sleeve buckles at thelocation of weakness in response to the radially inward force to contactthe therapy delivery element disposed within the inner sleeve.
 9. Theanchor of claim 8, wherein the outer sleeve includes an outer surfaceincluding at least one suture-receiving portion.
 10. The anchor of claim9, wherein the at least one suture-receiving portion includes at leastone suture groove oriented substantially concentrically to the axis. 11.The anchor of claim 9, wherein the radially inward force is appliedaround the suture-receiving portion by a suture material.
 12. The anchorof claim 8, wherein the at least two beams include a plurality of beamscircumferentially disposed around and defining a secondary lumen of theinner sleeve, wherein a pair of adjacent beams of the plurality of beamsare circumferentially connected at a deflection region, the pair ofadjacent beams of the plurality of beams being otherwise separated fromone another by a gap.
 13. The anchor of claim 12, wherein the secondarylumen is substantially concentric with the primary lumen.
 14. The anchorof claim 8, wherein the first slit and the second slit each extendradially, with respect to the inner sleeve, through the at least onebeam from an inner surface to an outer surface of the at least one beam.15. An anchor for securing a therapy delivery element to a desiredlocation within a living body, the anchor comprising: a deformable outersleeve including a primary lumen extending along an axis; an innersleeve including a plurality of beams connected at deflection regionsarranged around a secondary lumen, the inner sleeve located in theprimary lumen so that the secondary lumen is substantially concentricwith the primary lumen, wherein the inner sleeve is fixed within theprimary lumen of the outer sleeve; and a plurality of locations ofweakness in each of the beams, the plurality of locations of weaknessconfigured to facilitate localized deformation of the inner sleeve inresponse to a radially inward force applied around the outer sleeve, theplurality of locations of weakness including a plurality of slitsextending part-way through a beam width from both a first beam edge anda second beam edge, wherein the slits alternate from extending into thebeam width from the first edge to extending from the second edge withoutbeing in open communication with each other as the slits extend alongthe length of the beam, wherein the inner sleeve buckles at the slits inresponse to the radially inward force to grip the therapy deliveryelement disposed within the inner sleeve.
 16. The anchor of claim 15,wherein the outer sleeve includes an outer surface including at leastone suture-receiving portion.
 17. The anchor of claim 16, wherein the atleast one suture-receiving portion includes at least one suture groove.18. The anchor of claim 16, wherein the radially inward force is appliedaround the suture-receiving portion by a suture material.
 19. The anchorof claim 15, wherein the outer sleeve includes at least a portionextending beyond the inner sleeve.
 20. The anchor of claim 15, whereinthe inner sleeve includes a material configured to plastically deform inresponse to the radially inward force.